Browsing "Rheumatology" by Keyword : Rheumatoid arthritis

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 13 to 24 of 24

Pub YearTitleAuthor(s)
2021Health-related Quality of Life Outcomes of Adalimumab for Patients with Rheumatoid Arthritis in Korea김현아
2022Implications of Persistent Pain in Patients With Rheumatoid Arthritis Despite Remission Status: Data From the KOBIO Registry김현아
2021KOBIO, the first web-based Korean biologics registry operated with a unified platform among distinct disease entities김현아
2019Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study서창희
1999Open Clinical Trial of Methotrexate Alone and Combination of Methotrexate and Hydroxychloroquine in the Treatment of Rheumatoid Arthritis서창희
2020Preclinical rheumatoid arthritis and rheumatoid arthritis prevention김현아
2014Prediction for TNF Inhibitor Users in RA Patients According to Reimbursement Criteria Based on DAS28김현아, 서창희
2018Productivity Loss of Rheumatoid Arthritis Patients according to the Their Stages of the Disease Activity Score서창희
2018Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis서창희
2023Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data서창희
2018Transaminase Changes in Korean Rheumatoid Arthritis Patients with Chronic Hepatitis C after Biologic Therapy서창희
2023Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry김지원, 김현아, 서창희, 정주양
1

Browse